UniProt ID | PACN2_HUMAN | |
---|---|---|
UniProt AC | Q9UNF0 | |
Protein Name | Protein kinase C and casein kinase substrate in neurons protein 2 | |
Gene Name | PACSIN2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 486 | |
Subcellular Localization |
Cytoplasm. Cytoplasm, cytoskeleton. Cytoplasmic vesicle membrane Peripheral membrane protein Cytoplasmic side. Early endosome. Recycling endosome membrane. Cell projection, ruffle membrane Peripheral membrane protein Cytoplasmic side. Cell membrane P |
|
Protein Description | Lipid-binding protein that is able to promote the tubulation of the phosphatidic acid-containing membranes it preferentially binds. Plays a role in intracellular vesicle-mediated transport. Involved in the endocytosis of cell-surface receptors like the EGF receptor, contributing to its internalization in the absence of EGF stimulus. May also play a role in the formation of caveolae at the cell membrane. Recruits DNM2 to caveolae, and thereby plays a role in caveola-mediated endocytosis.. | |
Protein Sequence | MSVTYDDSVGVEVSSDSFWEVGNYKRTVKRIDDGHRLCSDLMNCLHERARIEKAYAQQLTEWARRWRQLVEKGPQYGTVEKAWMAFMSEAERVSELHLEVKASLMNDDFEKIKNWQKEAFHKQMMGGFKETKEAEDGFRKAQKPWAKKLKEVEAAKKAHHAACKEEKLAISREANSKADPSLNPEQLKKLQDKIEKCKQDVLKTKEKYEKSLKELDQGTPQYMENMEQVFEQCQQFEEKRLRFFREVLLEVQKHLDLSNVAGYKAIYHDLEQSIRAADAVEDLRWFRANHGPGMAMNWPQFEEWSADLNRTLSRREKKKATDGVTLTGINQTGDQSLPSKPSSTLNVPSNPAQSAQSQSSYNPFEDEDDTGSTVSEKDDTKAKNVSSYEKTQSYPTDWSDDESNNPFSSTDANGDSNPFDDDATSGTEVRVRALYDYEGQEHDELSFKAGDELTKMEDEDEQGWCKGRLDNGQVGLYPANYVEAIQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
39 | Phosphorylation | DDGHRLCSDLMNCLH CCHHHHHHHHHHHHH | 38.07 | - | |
53 | Acetylation | HERARIEKAYAQQLT HHHHHHHHHHHHHHH | 44.30 | 25953088 | |
53 | Malonylation | HERARIEKAYAQQLT HHHHHHHHHHHHHHH | 44.30 | 26320211 | |
53 | Ubiquitination | HERARIEKAYAQQLT HHHHHHHHHHHHHHH | 44.30 | - | |
72 | Ubiquitination | RWRQLVEKGPQYGTV HHHHHHHHCCCCCHH | 69.30 | - | |
76 | Phosphorylation | LVEKGPQYGTVEKAW HHHHCCCCCHHHHHH | 20.21 | 28152594 | |
78 | Phosphorylation | EKGPQYGTVEKAWMA HHCCCCCHHHHHHHH | 22.13 | 28152594 | |
88 | Phosphorylation | KAWMAFMSEAERVSE HHHHHHHCHHHHHHH | 27.48 | - | |
105 | Sulfoxidation | LEVKASLMNDDFEKI HHHHHHHCCCCHHHH | 4.84 | 21406390 | |
111 | Ubiquitination | LMNDDFEKIKNWQKE HCCCCHHHHHHHHHH | 60.00 | - | |
117 | Acetylation | EKIKNWQKEAFHKQM HHHHHHHHHHHHHHH | 42.50 | 19608861 | |
117 | Ubiquitination | EKIKNWQKEAFHKQM HHHHHHHHHHHHHHH | 42.50 | 19608861 | |
122 | Malonylation | WQKEAFHKQMMGGFK HHHHHHHHHHHCCHH | 33.17 | 32601280 | |
129 | Acetylation | KQMMGGFKETKEAED HHHHCCHHHCHHHHH | 68.68 | 25953088 | |
129 | Ubiquitination | KQMMGGFKETKEAED HHHHCCHHHCHHHHH | 68.68 | - | |
131 | Phosphorylation | MMGGFKETKEAEDGF HHCCHHHCHHHHHHH | 34.47 | 30576142 | |
167 | 2-Hydroxyisobutyrylation | HAACKEEKLAISREA HHHHHHHHHHHHHHH | 44.29 | - | |
167 | Ubiquitination | HAACKEEKLAISREA HHHHHHHHHHHHHHH | 44.29 | - | |
171 (in isoform 2) | Phosphorylation | - | 20.61 | 24719451 | |
171 | Phosphorylation | KEEKLAISREANSKA HHHHHHHHHHHHCCC | 20.61 | 24719451 | |
176 | Phosphorylation | AISREANSKADPSLN HHHHHHHCCCCCCCC | 35.95 | 28122231 | |
177 (in isoform 2) | Ubiquitination | - | 57.53 | 21906983 | |
177 (in isoform 1) | Ubiquitination | - | 57.53 | 21906983 | |
177 | Ubiquitination | ISREANSKADPSLNP HHHHHHCCCCCCCCH | 57.53 | 2190698 | |
181 | Phosphorylation | ANSKADPSLNPEQLK HHCCCCCCCCHHHHH | 41.13 | 28122231 | |
188 | Ubiquitination | SLNPEQLKKLQDKIE CCCHHHHHHHHHHHH | 51.65 | - | |
193 | Acetylation | QLKKLQDKIEKCKQD HHHHHHHHHHHHHHH | 39.54 | 25953088 | |
213 | Ubiquitination | EKYEKSLKELDQGTP HHHHHHHHHHHCCCH | 64.42 | - | |
213 (in isoform 2) | Ubiquitination | - | 64.42 | - | |
263 (in isoform 2) | Phosphorylation | - | 6.36 | 27642862 | |
264 | Ubiquitination | LSNVAGYKAIYHDLE HHHCCCHHHHHHCHH | 27.65 | - | |
267 | Phosphorylation | VAGYKAIYHDLEQSI CCCHHHHHHCHHHHH | 8.30 | - | |
267 (in isoform 2) | Phosphorylation | - | 8.30 | 27642862 | |
273 | Phosphorylation | IYHDLEQSIRAADAV HHHCHHHHHHHHHHH | 12.50 | 23186163 | |
284 | Methylation | ADAVEDLRWFRANHG HHHHHHHHHHHHHCC | 42.69 | 115486319 | |
294 | Sulfoxidation | RANHGPGMAMNWPQF HHHCCCCCCCCCHHH | 3.44 | 30846556 | |
296 | Sulfoxidation | NHGPGMAMNWPQFEE HCCCCCCCCCHHHHH | 3.91 | 30846556 | |
305 | Phosphorylation | WPQFEEWSADLNRTL CHHHHHHHHHHHHHH | 18.38 | 22167270 | |
311 (in isoform 2) | Phosphorylation | - | 28.19 | 24719451 | |
311 | Phosphorylation | WSADLNRTLSRREKK HHHHHHHHHCHHHHH | 28.19 | 22167270 | |
313 | Phosphorylation | ADLNRTLSRREKKKA HHHHHHHCHHHHHHC | 28.78 | 22167270 | |
313 (in isoform 2) | Phosphorylation | - | 28.78 | 24719451 | |
321 | Phosphorylation | RREKKKATDGVTLTG HHHHHHCCCCEEEEE | 42.01 | 25159151 | |
325 (in isoform 2) | Phosphorylation | - | 24.92 | 30108239 | |
327 (in isoform 2) | Phosphorylation | - | 27.01 | 28450419 | |
332 (in isoform 2) | Phosphorylation | - | 37.93 | 28450419 | |
336 (in isoform 2) | Phosphorylation | - | 47.16 | 28450419 | |
336 | Phosphorylation | INQTGDQSLPSKPSS ECCCCCCCCCCCCCC | 47.16 | 25159151 | |
339 (in isoform 2) | Phosphorylation | - | 63.59 | 23663014 | |
339 | Phosphorylation | TGDQSLPSKPSSTLN CCCCCCCCCCCCCCC | 63.59 | 24719451 | |
342 (in isoform 2) | Phosphorylation | - | 39.43 | 23663014 | |
342 | Phosphorylation | QSLPSKPSSTLNVPS CCCCCCCCCCCCCCC | 39.43 | 22199227 | |
343 (in isoform 2) | Phosphorylation | - | 45.50 | 23663014 | |
343 | Phosphorylation | SLPSKPSSTLNVPSN CCCCCCCCCCCCCCC | 45.50 | 22199227 | |
344 | Phosphorylation | LPSKPSSTLNVPSNP CCCCCCCCCCCCCCH | 27.04 | 22199227 | |
345 (in isoform 2) | Phosphorylation | - | 7.03 | 25849741 | |
346 (in isoform 2) | Phosphorylation | - | 43.68 | 25849741 | |
347 (in isoform 2) | Phosphorylation | - | 6.55 | 23663014 | |
354 | Phosphorylation | VPSNPAQSAQSQSSY CCCCHHHCCCCCCCC | 30.31 | 30576142 | |
357 | Phosphorylation | NPAQSAQSQSSYNPF CHHHCCCCCCCCCCC | 31.57 | 30576142 | |
359 | Phosphorylation | AQSAQSQSSYNPFED HHCCCCCCCCCCCCC | 39.78 | 30576142 | |
360 | Phosphorylation | QSAQSQSSYNPFEDE HCCCCCCCCCCCCCC | 22.69 | 30576142 | |
361 | Phosphorylation | SAQSQSSYNPFEDED CCCCCCCCCCCCCCC | 31.91 | 28270605 | |
370 | Phosphorylation | PFEDEDDTGSTVSEK CCCCCCCCCCCCCCC | 45.41 | 25159151 | |
372 | Phosphorylation | EDEDDTGSTVSEKDD CCCCCCCCCCCCCCC | 27.94 | 25159151 | |
373 | Phosphorylation | DEDDTGSTVSEKDDT CCCCCCCCCCCCCCC | 29.42 | 25159151 | |
375 | Phosphorylation | DDTGSTVSEKDDTKA CCCCCCCCCCCCCCC | 38.73 | 25159151 | |
380 | Phosphorylation | TVSEKDDTKAKNVSS CCCCCCCCCCCCCCC | 42.93 | 30576142 | |
383 | Ubiquitination | EKDDTKAKNVSSYEK CCCCCCCCCCCCCCC | 60.48 | - | |
386 | Phosphorylation | DTKAKNVSSYEKTQS CCCCCCCCCCCCCCC | 36.27 | 21712546 | |
387 | Phosphorylation | TKAKNVSSYEKTQSY CCCCCCCCCCCCCCC | 32.78 | 28796482 | |
388 | Phosphorylation | KAKNVSSYEKTQSYP CCCCCCCCCCCCCCC | 17.59 | 28796482 | |
391 | Phosphorylation | NVSSYEKTQSYPTDW CCCCCCCCCCCCCCC | 15.71 | 25850435 | |
393 | Phosphorylation | SSYEKTQSYPTDWSD CCCCCCCCCCCCCCC | 38.01 | 23927012 | |
394 | Phosphorylation | SYEKTQSYPTDWSDD CCCCCCCCCCCCCCC | 10.59 | 23927012 | |
394 (in isoform 2) | Phosphorylation | - | 10.59 | 27642862 | |
396 | Phosphorylation | EKTQSYPTDWSDDES CCCCCCCCCCCCCCC | 41.70 | 23927012 | |
396 (in isoform 2) | Phosphorylation | - | 41.70 | 27642862 | |
399 | Phosphorylation | QSYPTDWSDDESNNP CCCCCCCCCCCCCCC | 37.68 | 26503892 | |
403 | Phosphorylation | TDWSDDESNNPFSST CCCCCCCCCCCCCCC | 49.23 | 23927012 | |
408 | Phosphorylation | DESNNPFSSTDANGD CCCCCCCCCCCCCCC | 33.32 | 23927012 | |
409 | Phosphorylation | ESNNPFSSTDANGDS CCCCCCCCCCCCCCC | 30.59 | 26657352 | |
410 | Phosphorylation | SNNPFSSTDANGDSN CCCCCCCCCCCCCCC | 37.62 | 25137130 | |
416 | Phosphorylation | STDANGDSNPFDDDA CCCCCCCCCCCCCCC | 48.04 | 28464451 | |
424 | Phosphorylation | NPFDDDATSGTEVRV CCCCCCCCCCCEEEE | 34.38 | 28188228 | |
425 | Phosphorylation | PFDDDATSGTEVRVR CCCCCCCCCCEEEEE | 45.50 | 25850435 | |
427 | Phosphorylation | DDDATSGTEVRVRAL CCCCCCCCEEEEEEE | 30.95 | 23927012 | |
446 | Phosphorylation | GQEHDELSFKAGDEL CCCCCEEEECCCCCC | 23.74 | 25159151 | |
455 | Ubiquitination | KAGDELTKMEDEDEQ CCCCCCCCCCCCCCC | 53.57 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
313 | S | Phosphorylation | Kinase | PKC | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PACN2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PACN2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-117, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-370; SER-372; THR-373AND SER-375, AND MASS SPECTROMETRY. |